vs
Side-by-side financial comparison of Star Equity Holdings, Inc. (STRR) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $56.8M, roughly 1.6× Star Equity Holdings, Inc.). Vericel Corp runs the higher net margin — 25.0% vs -3.0%, a 28.0% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 23.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-9.0M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 29.5%).
Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
STRR vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $56.8M | $92.9M |
| Net Profit | $-1.7M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | -0.2% | 24.1% |
| Net Margin | -3.0% | 25.0% |
| Revenue YoY | 69.0% | 23.3% |
| Net Profit YoY | -192.1% | 17.3% |
| EPS (diluted) | $-0.49 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.8M | $92.9M | ||
| Q3 25 | $48.0M | $67.5M | ||
| Q2 25 | $35.5M | $63.2M | ||
| Q1 25 | $31.9M | $52.6M | ||
| Q4 24 | $33.6M | $75.4M | ||
| Q3 24 | $36.9M | $57.9M | ||
| Q2 24 | $35.7M | $52.7M | ||
| Q1 24 | $33.9M | $51.3M |
| Q4 25 | $-1.7M | $23.2M | ||
| Q3 25 | $-1.8M | $5.1M | ||
| Q2 25 | $-688.0K | $-553.0K | ||
| Q1 25 | $-1.8M | $-11.2M | ||
| Q4 24 | $-585.0K | $19.8M | ||
| Q3 24 | $-846.0K | $-901.0K | ||
| Q2 24 | $-441.0K | $-4.7M | ||
| Q1 24 | $-2.9M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | 43.0% | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | 50.5% | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | -0.2% | 24.1% | ||
| Q3 25 | -3.4% | 5.1% | ||
| Q2 25 | -0.6% | -3.2% | ||
| Q1 25 | -5.4% | -24.3% | ||
| Q4 24 | -0.4% | 24.5% | ||
| Q3 24 | -1.2% | -4.3% | ||
| Q2 24 | -0.5% | -11.5% | ||
| Q1 24 | -9.0% | -10.7% |
| Q4 25 | -3.0% | 25.0% | ||
| Q3 25 | -3.7% | 7.5% | ||
| Q2 25 | -1.9% | -0.9% | ||
| Q1 25 | -5.5% | -21.4% | ||
| Q4 24 | -1.7% | 26.3% | ||
| Q3 24 | -2.3% | -1.6% | ||
| Q2 24 | -1.2% | -8.9% | ||
| Q1 24 | -8.6% | -7.5% |
| Q4 25 | $-0.49 | $0.46 | ||
| Q3 25 | $-0.54 | $0.10 | ||
| Q2 25 | $-0.23 | $-0.01 | ||
| Q1 25 | $-0.59 | $-0.23 | ||
| Q4 24 | $-0.21 | $0.40 | ||
| Q3 24 | $-0.28 | $-0.02 | ||
| Q2 24 | $-0.15 | $-0.10 | ||
| Q1 24 | $-0.95 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.3M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $65.7M | $354.6M |
| Total Assets | $113.2M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | $137.5M | ||
| Q3 25 | $15.4M | $135.4M | ||
| Q2 25 | $16.8M | $116.9M | ||
| Q1 25 | $16.6M | $112.9M | ||
| Q4 24 | $17.0M | $116.2M | ||
| Q3 24 | $15.8M | $101.7M | ||
| Q2 24 | $14.7M | $102.5M | ||
| Q1 24 | $20.4M | $110.6M |
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $65.7M | $354.6M | ||
| Q3 25 | $67.8M | $321.9M | ||
| Q2 25 | $40.1M | $306.8M | ||
| Q1 25 | $39.5M | $295.5M | ||
| Q4 24 | $40.4M | $292.0M | ||
| Q3 24 | $42.9M | $257.5M | ||
| Q2 24 | $42.6M | $243.0M | ||
| Q1 24 | $44.3M | $233.9M |
| Q4 25 | $113.2M | $488.0M | ||
| Q3 25 | $117.1M | $453.3M | ||
| Q2 25 | $55.6M | $435.6M | ||
| Q1 25 | $53.2M | $424.6M | ||
| Q4 24 | $52.6M | $432.7M | ||
| Q3 24 | $52.6M | $390.4M | ||
| Q2 24 | $52.6M | $376.8M | ||
| Q1 24 | $52.6M | $356.7M |
| Q4 25 | — | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-7.3M | $15.0M |
| Free Cash FlowOCF − Capex | $-9.0M | $12.8M |
| FCF MarginFCF / Revenue | -15.8% | 13.8% |
| Capex IntensityCapex / Revenue | 3.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.0M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.3M | $15.0M | ||
| Q3 25 | $-2.7M | $22.1M | ||
| Q2 25 | $139.0K | $8.2M | ||
| Q1 25 | $-802.0K | $6.6M | ||
| Q4 24 | $-2.8M | $22.2M | ||
| Q3 24 | $1.3M | $10.2M | ||
| Q2 24 | $-4.3M | $18.5M | ||
| Q1 24 | $-1.8M | $7.2M |
| Q4 25 | $-9.0M | $12.8M | ||
| Q3 25 | $-3.4M | $19.5M | ||
| Q2 25 | $102.0K | $81.0K | ||
| Q1 25 | $-808.0K | $-7.6M | ||
| Q4 24 | $-2.8M | $8.5M | ||
| Q3 24 | $1.3M | $-9.2M | ||
| Q2 24 | $-4.3M | $1.8M | ||
| Q1 24 | $-1.8M | $-6.8M |
| Q4 25 | -15.8% | 13.8% | ||
| Q3 25 | -7.0% | 28.8% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | -2.5% | -14.5% | ||
| Q4 24 | -8.3% | 11.2% | ||
| Q3 24 | 3.4% | -15.9% | ||
| Q2 24 | -12.0% | 3.4% | ||
| Q1 24 | -5.3% | -13.3% |
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 1.3% | 3.9% | ||
| Q2 25 | 0.1% | 12.9% | ||
| Q1 25 | 0.0% | 27.0% | ||
| Q4 24 | 0.1% | 18.3% | ||
| Q3 24 | 0.0% | 33.5% | ||
| Q2 24 | 0.0% | 31.8% | ||
| Q1 24 | 0.0% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STRR
| Revenue From Other Contracts With Customers | $27.6M | 49% |
| Other | $24.3M | 43% |
| Energy Services Segment | $4.9M | 9% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |